Shares of Cognizant Technology Solutions rose 2.1% in pre-open trading after Wedbush shifted its rating on the company from Neutral to Outperform and increased its price objective from $56 to $70 - a target the firm described as roughly an 11x multiple on 2027 earnings estimates.
Wedbush pointed to what it called accelerating momentum in Cognizant's AI Builder strategy, saying enterprise contracts in the eight- and nine-figure range are likely to move from the pipeline to recognized revenue during the second half of 2026. The firm also highlighted a 70% surge in total contract value and robust first-quarter bookings growth as supporting evidence for the upgrade.
The analyst re-rating arrived on a constructive fundamental backdrop. Cognizant reported adjusted earnings of $1.40 per share for the first quarter of 2026, an increase of 13.8% year over year and about 5% ahead of consensus. Trailing 12-month bookings hit $29.6 billion, a new high for the company, reflecting 21% bookings growth in the quarter.
Management has raised full-year 2026 adjusted operating margin guidance and backed an expanded $2 billion share repurchase program, moves that underscore management's confidence in the firm's financial trajectory. Those actions, combined with the bookings strength, were noted as contributing to the positive investor response.
The pre-market gain is particularly notable given widespread weakness across major indexes the same morning. The S&P 500 was down 2.6%, the Dow Jones fell 1.4%, and the NASDAQ declined 4.2% - yet Cognizant's company-specific catalyst appeared to provide a counterweight to the risk-off tone affecting the broader technology sector.
Peers in the sector, including Accenture and EPAM Systems, were cited as facing the same macro headwinds, but the combination of the Wedbush upgrade and signs of AI-related contract conversion created a clearer path for buyers in CTSH. Despite the uptick, the stock remains materially below its 52-week high of $87.03, leaving room for additional recovery should the AI contract pipeline materialize as expected.
In sum, Wedbush's re-rating - which paired a higher price target with a more constructive view on AI-driven revenue conversion - was identified as the primary driver of today's move. That shift in analyst stance is helping to attract demand even as the broader technology sector experiences selling pressure.
Summary
Cognizant shares climbed after Wedbush upgraded the stock and raised its price target, citing stronger bookings, a surge in total contract value and momentum in the company's AI Builder program. Recent first-quarter 2026 results, improved margin guidance and an expanded $2 billion buyback were also highlighted as supportive.
Key points
- Wedbush upgraded Cognizant to Outperform and raised its price target from $56 to $70, implying about an 11x multiple on 2027 earnings estimates.
- Company fundamentals include Q1 adjusted EPS of $1.40 (up 13.8% year over year and ~5% above consensus) and trailing 12-month bookings of $29.6 billion, a record high with 21% quarterly growth.
- Management increased full-year 2026 adjusted operating margin guidance and supported an expanded $2 billion share repurchase program.
Risks and uncertainties
- Macroeconomic and market weakness - major indexes were sharply lower on the day, which could pressure technology sector sentiment and share prices broadly.
- Execution risk tied to AI contract conversion - the thesis depends on large enterprise contracts moving from the pipeline to recognized revenue in the second half of 2026.
- Valuation and recovery potential - despite the upgrade, the stock remains well below its 52-week high, indicating that further upside depends on realization of the stated bookings and revenue conversion.